Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. (LMAT) Stock Overview

Explore LeMaitre Vascular, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LMAT●NASDAQ
HealthcareMedical - Instruments & Supplies
$95.59
$1.90(1.95%)
U.S. Market opens in 14h 27m

LeMaitre Vascular, Inc. (LMAT)

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio34.78
EPS (TTM)$2.58
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$115.73
3 Months$110.89
1 Year Target$107.25

LMAT Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of LeMaitre Vascular, Inc. (NASDAQ: LMAT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, LeMaitre Vascular, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of LMAT on the NASDAQ shows an RSI of 43.37, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $107.25 for the NASDAQ listing.

Key metrics behind LeMaitre Vascular, Inc.'s NASDAQ-traded stock include a P/E ratio of 34.78 and a market capitalization of 2.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of LMAT on the NASDAQ.

Price Performance (NASDAQ: LMAT)

1-Day Change
-1.95%
5-Day Change
-6.59%
1-Month Change
3.62%
3-Month Change
-15.74%
6-Month Change
13.50%
Year-to-Date (YTD) Change
17.87%
1-Year Change
18.35%
3-Year Change
50.51%
5-Year Change
75.20%
All-Time (Max) Change
1441.77%

Contact Information

https://www.lemaitre.com
781 221 2266
63 Second Avenue, Burlington, MA, 01803

Company Facts

6,550 Employees
IPO DateOct 19, 2006
CountryUS
Actively Trading

Frequently Asked Questions